Molecular mechanisms underlying the beneficial effects of Urocortin 2 in pulmonary arterial hypertension
9 July 2016 (08:30 - 18:00)
Organised by: 
Abstract
About the speaker
Hospital Center of Entre Douro and Vouga, Santa Maria da Feira (Portugal)
6 More presentations in this session
Access the full session
The Event
Frontiers in CardioVascular Biology 2016
9 July 2016
08:30 CET
